KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Analyst Earnings Estimates
NASDAQ:KZIA - Nasdaq - US48669G2049 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.1K -99.99% | 22.6K 976.19% | 2.32M 10,165.49% | -100.00% | 63.552M | 90.1M 41.77% | 110.59M 22.74% | |||
| EBITDA YoY % growth | N/A -1,735.97% | N/A -9.90% | N/A 124.14% | 7.2M 16.50% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -25.382M -300.46% | -24.125M 4.95% | -27.193M -12.72% | -36.685M -34.91% | -41.408M -12.87% | -44.363M -7.14% | 27.763M 162.58% | 47.228M 70.11% | 61.386M 29.98% | |
| Operating Margin | -1,208,671.43% | -106,745.58% | -1,172.11% | N/A | N/A | N/A | 43.69% | 52.42% | 55.51% | |
| EPS YoY % growth | N/A -8,174.48% | N/A 89.43% | N/A 101.00% | -5.30 -47,372.73% | -2.59 51.15% | -2.01 22.44% | 0.70 134.94% | 1.20 71.37% | 1.60 33.33% |
All data in AUD
| Q2 / 25 | Q4 / 25 | Q2 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -3.49 | -2.25 | -1.38 60.53% | -1.22 45.70% |
| Revenue Q2Q % growth | -100.00% | -100.00% | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.401M -75.16% | -21.285M -14.60% | -19.876M -29.05% | -21.532M -1.16% |
All data in AUD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -1.90 -118.14% | -0.51 | -1.39 | -272.55% |
| Q4 2022 Q2Q % growth | -0.87 | -0.10 | -0.77 | -753.92% |
| Q2 2021 Q2Q % growth | -22.22% | -0.16 | % | |
| Q2 2020 Q2Q % growth | 49.80% | -0.13 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 6.5K 6,400.00% | % | ||
| Q4 2023 Q2Q % growth | 22.4K -100.00% | 23.46K | -23.46K | -100.00% |
| Q2 2023 Q2Q % growth | 100 -95.00% | % | ||
| Q4 2022 Q2Q % growth | 100 -100.00% | 518.16K | -518.06K | -99.98% |
| Q2 2022 Q2Q % growth | 2K -93.51% | % | ||
| Q4 2021 Q2Q % growth | 15.194M 45,527.93% | % | ||
| Q2 2021 Q2Q % growth | 30.8K -5.52% | 1.522M | -1.492M | -97.98% |
| Q4 2020 Q2Q % growth | 33.3K -66.57% | % | ||
| Q2 2020 Q2Q % growth | 32.6K 13.19% | 1.522M | -1.49M | -97.86% |
| Q2 2019 Q2Q % growth | 28.8K | 3.12M | -3.091M | -99.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | -37242.9% | -37242.9% |
| Revenue | N/A | N/A | -100% | -100% |